What question did this study set out to answer?

Identifying patients who will benefit from immune checkpoint inhibitors in melanoma treatment is crucial due to variable responses and adverse effects.

June 12, 2026International Journal of Molecular SciencesOpen Access

Predicting Response to Immune Checkpoint Inhibitors in Melanoma: Emerging Approaches in Digital Pathology, Spatial Profiling and Machine Learning

View Full Paper

Ask AI

Bookmark

Authors

JBJakub BanaszekMedical University of Lublin DBDawid BąkMedical University of Lublin KBKinga BarańskaMedical University of Lublin

Discussion

Member takes

Implication

Narrative review reveals emerging digital pathology and machine learning methods predicting ICI response in melanoma, suggesting future research directions.

Key Points

Identifying patients who will benefit from immune checkpoint inhibitors in melanoma treatment is crucial due to variable responses and adverse effects.
Narrative review of studies using digital pathology tools and machine learning algorithms
Assessment of immune infiltration and its spatial distribution
Evaluation of immune phenotypes and local immune niche organization
Existing biomarkers like PD-L1 have limited predictive value for ICI response
Integration of quantitative immune assessments yields higher predictive accuracy
Challenges include methodological standardization and data validation issues

Cite This Study

Banaszek et al. (2026) studied this question.

synapsesocial.com/papers/6a2ba34a8101cf8926f01fe3 https://doi.org/10.3390/ijms27125244

View Full Paper

Ask AI

Bookmark

June 12, 2026International Journal of Molecular SciencesOpen Access

Predicting Response to Immune Checkpoint Inhibitors in Melanoma: Emerging Approaches in Digital Pathology, Spatial Profiling and Machine Learning

View Full Paper

Ask AI

Bookmark

Authors

JBJakub BanaszekMedical University of Lublin DBDawid BąkMedical University of Lublin KBKinga BarańskaMedical University of Lublin

Discussion

Member takes

Implication

Narrative review reveals emerging digital pathology and machine learning methods predicting ICI response in melanoma, suggesting future research directions.

Key Points

Identifying patients who will benefit from immune checkpoint inhibitors in melanoma treatment is crucial due to variable responses and adverse effects.
Narrative review of studies using digital pathology tools and machine learning algorithms
Assessment of immune infiltration and its spatial distribution
Evaluation of immune phenotypes and local immune niche organization
Existing biomarkers like PD-L1 have limited predictive value for ICI response
Integration of quantitative immune assessments yields higher predictive accuracy
Challenges include methodological standardization and data validation issues

Cite This Study

Banaszek et al. (2026) studied this question.

synapsesocial.com/papers/6a2ba34a8101cf8926f01fe3 https://doi.org/10.3390/ijms27125244

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark